Stocks and Investing
Stocks and Investing
Thu, October 28, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Steve Valiquette Maintained (TDOC) at Hold with Decreased Target to $150 on, Oct 28th, 2021
Steve Valiquette of Barclays, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $170 to $150 on, Oct 28th, 2021.
Steve has made no other calls on TDOC in the last 4 months.
There are 5 other peers that have a rating on TDOC. Out of the 5 peers that are also analyzing TDOC, 2 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Monday, August 2nd, 2021
- George Hill of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $153 on, Wednesday, July 28th, 2021
These are the ratings of the 3 analyists that currently disagree with Steve
- Stephen Baxter of "Wells Fargo" Initiated at Buy and Held Target at $156 on, Tuesday, October 19th, 2021
- Charles Ryhee of "Cowen & Co." Maintained at Buy with Decreased Target to $188 on, Monday, August 9th, 2021
- Donald Hooker of "Keybanc" Maintained at Buy with Decreased Target to $180 on, Wednesday, July 28th, 2021
Contributing Sources